 | • レポートコード：TPM-NV168 • 出版社/出版日：Transparency Market Research / 2019年10月28日 • レポート形態：英文、PDF、158ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、コラーゲン及びHAベース生体材料の世界市場について調べ、コラーゲン及びHAベース生体材料の世界市場規模、市場動向、市場シェア、市場環境、市場予測、種類別（尿失禁、角膜シールド、美顔用皮膚充填剤、創傷包帯、その他）分析、用途別（食品、医薬品、化粧品、その他）分析、関連企業情報などをまとめました。 ・コラーゲン及びHAベース生体材料の市場概要 ・コラーゲン及びHAベース生体材料の市場動向 ・コラーゲン及びHAベース生体材料の価格分析 ・コラーゲン及びHAベース生体材料の世界市場規模・予測 ・コラーゲン及びHAベース生体材料市場：種類別（尿失禁、角膜シールド、美顔用皮膚充填剤、創傷包帯、その他） ・コラーゲン及びHAベース生体材料市場：用途別（食品、医薬品、化粧品、その他） ・地域別分析（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争環境・関連企業分析 |
Facial aesthetic treatments, in recent years, have been focused on high quality results with minimal steps involved. And while for years, collagen and hyaluronic acid (HA)-based biomaterials have been used for improving would healing and cosmetic surgeries, currently, there has been a flurry of activity, all aimed at enhancing patient outcomes. These innovations include several advanced dermal fillers that have been developed to cater to the skincare needs of people, globally. For instance, in May 2018, Nestlé Skin Health’s dermal filler Restylane® Lyft was approved by the Food and Drug Association for aesthetic and cosmetic purposes. According to this recent study by Transparency Market Research (TMR), the collagen and HA-based biomaterials market is set to grow at an average CAGR of ~5% during the forecast period of 2019 to 2027. The study projects a rise in investments toward research & development (R&D) that are predominantly aimed at discovering collagen and HA-based biomaterials that can be used in next-generation, innovative products such as injectable dermal fillers, in various cosmetic surgeries.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Collagen and HA-based Biomaterials Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Collagen and HA-based Biomaterials Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Key Industry Developments
5.2. Major Research Institutes Involved
5.3. Technological Advancements
5.4. Key Mergers & Acquisitions
5.5. Pricing Analysis
6. Global Collagen and HA-based Biomaterials Market Value and Forecast, by Type
6.1. Introduction & Definition
6.2. Global Collagen and HA-based Biomaterials Market Value (US$ Mn)Forecast, by Type, 2017–2027
6.2.1. Urinary Incontinence
6.2.2. Corneal Shields
6.2.3. Facial Aesthetic Dermal Fillers
6.2.4. Wound Dressings
6.2.5. Others
6.3. Global Collagen and HA-based Biomaterials Market Attractiveness, by Type
7. Global Collagen and HA-based Biomaterials Market Value and Forecast, by Application
7.1. Introduction
7.2. Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
7.2.1. Food
7.2.2. Medicine
7.2.3. Cosmetics
7.2.4. Others
7.3. Global Collagen and HA-based Biomaterials Market Attractiveness, by Application
8. Global Collagen and HA-based Biomaterials Market Value and Forecast, by Region
8.1. Introduction
8.2. Collagen and HA-based biomaterials Market Value (US$ Mn) Forecast, by Region, 2017–2027
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Collagen and HA-based Biomaterials Market Attractiveness, by Region
9. North America Collagen and HA-based Biomaterials Market Analysis and Forecast
9.1. Introduction
9.2. North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027
9.2.1. Urinary Incontinence
9.2.2. Corneal Shields
9.2.3. Facial Aesthetic Dermal Fillers
9.2.4. Wound Dressings
9.2.5. Others
9.3. North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
9.3.1. Food
9.3.2. Medicine
9.3.3. Cosmetics
9.3.4. Others
9.4. North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
9.4.1. U.S.
9.4.2. Canada
9.5. North America Collagen and HA-based Biomaterials Market Attractiveness Analysis
9.5.1. By Type
9.5.2. By Application
9.5.3. By Country/Sub-region
10. Europe Collagen and HA-based Biomaterials Market Analysis and Forecast
10.1. Introduction
10.2. Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027
10.2.1. Urinary Incontinence
10.2.2. Corneal Shields
10.2.3. Facial Aesthetic Dermal Fillers
10.2.4. Wound Dressings
10.2.5. Others
10.3. Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
10.3.1. Food
10.3.2. Medicine
10.3.3. Cosmetics
10.3.4. Others
10.4. Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Europe Collagen and HA-based Biomaterials Market Attractiveness Analysis
10.5.1. By Type
10.5.2. By Application
10.5.3. By Country/Sub-region
11. Asia Pacific Collagen and HA-based Biomaterials Market Analysis and Forecast
11.1. Introduction
11.2. Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027
11.2.1. Urinary Incontinence
11.2.2. Corneal Shields
11.2.3. Facial Aesthetic Dermal Fillers
11.2.4. Wound Dressings
11.2.5. Others
11.3. Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
11.3.1. Food
11.3.2. Medicine
11.3.3. Cosmetics
11.3.4. Others
11.4. Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Collagen and HA-based Biomaterials Market Attractiveness Analysis
11.5.1. By Type
11.5.2. By Application
11.5.3. By Country/Sub-region
12. Latin America Collagen and HA-based biomaterials Market Analysis and Forecast
12.1. Introduction
12.2. Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027
12.2.1. Urinary Incontinence
12.2.2. Corneal Shields
12.2.3. Facial Aesthetic Dermal Fillers
12.2.4. Wound Dressings
12.2.5. Others
12.3. Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
12.3.1. Food
12.3.2. Medicine
12.3.3. Cosmetics
12.3.4. Others
12.4. Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Collagen and HA-based Biomaterials Market Attractiveness Analysis
12.5.1. By Type
12.5.2. By Application
12.5.3. By Country/Sub-region
13. Middle East & Africa Collagen and HA-based biomaterials Market Analysis and Forecast
13.1. Introduction
13.2. Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027
13.2.1. Urinary Incontinence
13.2.2. Corneal Shields
13.2.3. Facial Aesthetic Dermal Fillers
13.2.4. Wound Dressings
13.2.5. Others
13.3. Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027
13.3.1. Food
13.3.2. Medicine
13.3.3. Cosmetics
13.3.4. Others
13.4. Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Middle East & Africa Collagen and HA-based Biomaterials Market Attractiveness Analysis
13.5.1. By Type
13.5.2. By Application
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Global Collagen and HA-based Biomaterials Market Share Analysis, by Company (2018)
14.3. Company Profiles
14.3.1. Collagen Solutions Plc
14.3.1.1. Company Description
14.3.1.2. Business Overview
14.3.1.3. Financial Overview
14.3.1.4. Strategic Overview
14.3.1.5. SWOT Analysis
14.3.2. Sanofi
14.3.2.1. Company Description
14.3.2.2. Business Overview
14.3.2.3. Financial Overview
14.3.2.4. Strategic Overview
14.3.2.5. SWOT Analysis
14.3.3. Allergan plc
14.3.3.1. Company Description
14.3.3.2. Business Overview
14.3.3.3. Financial Overview
14.3.3.4. Strategic Overview
14.3.3.5. SWOT Analysis
14.3.4. Anika Therapeutics, Inc.
14.3.4.1. Company Description
14.3.4.2. Business Overview
14.3.4.3. Financial Overview
14.3.4.4. Strategic Overview
14.3.4.5. SWOT Analysis
14.3.5. Bausch Health Companies Inc.
14.3.5.1. Company Description
14.3.5.2. Business Overview
14.3.5.3. Financial Overview
14.3.5.4. Strategic Overview
14.3.5.5. SWOT Analysis
14.3.6. Abbott Laboratories
14.3.6.1. Company Description
14.3.6.2. Business Overview
14.3.6.3. Financial Overview
14.3.6.4. Strategic Overview
14.3.6.5. SWOT Analysis
14.3.7. Johnson & Johnson Services, Inc.
14.3.7.1. Company Description
14.3.7.2. Business Overview
14.3.7.3. Financial Overview
14.3.7.4. Strategic Overview
14.3.7.5. SWOT Analysis
14.3.8. Galderma Laboratories L.P. (Nestle Skin Health)
14.3.8.1. Company Description
14.3.8.2. Business Overview
14.3.8.3. Financial Overview
14.3.8.4. Strategic Overview
14.3.8.5. SWOT Analysis
14.3.9. BioCell Technology LLC
14.3.9.1. Company Description
14.3.9.2. Business Overview
14.3.9.3. Financial Overview
14.3.9.4. Strategic Overview
14.3.9.5. SWOT Analysis